Categories: News

Notification about final share buy-back

Joint stock company “Olainfarm”, hereinafter referred to as – “the Company”, hereby informs that by decision No. 185 of 28th December 2021, the Financial and Capital Market Commission allowed AS “AB CITY”, registration number 40203174414, to carry out the Company’s  final share buy-back. Final buy-back price is 9,26 EUR per share. The value of one share has been calculated in accordance with Section 74, Paragraphs one, Clause 3 of the Financial Instruments Market Law.

The entry date is the next working day after the date of publishing the information in the official gazette Latvijas Vēstnesis and it is 3rd January, 2022.

The payment for shares will take place the next working day after the entry day, that is 4th January, 2022.

The prospectus of the final share buy-back is available on the website of Nasdaq Riga or in Olaine at the premises of the Joint Stock Company “Olainfarm”, Rūpnīcu Street 5, from 10.00 to17.00, by prior appointment by phone (+371) 67013705.

Attached: Prospectus for the final share buy-back in Latvian of AS “Olainfarm” shares.

Additional information:  
Jānis Leimanis
JSC Olainfarm Member of the Management Board
Tel. +371 29269424
E-pasts: janis.leimanis@olainfarm.com

Attachment

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

8 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

8 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago